glp-1 colorectal cancer death risk study november 2025 mortality If you are taking a GLP-1 for diabetes or weight loss, a new study found it may also be lowering GLP-1 receptor agonists show anti-cancer

The following are considered clear liqui ds : Water Pulp-free clear fruit juice (e.g

Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission

Hepatic Steatosis : Recently, a sub-study of the phase 3 clinical trial SURPASS-3 showed that, among patients receiving metformin and/or SGLT2 inhibitors, the addition of tirzepatide (10 or 15 mg) as compared to insulin degludec was able to significantly reduce hepatic fat content (evaluated by magnetic resonance) after 52 weeks of treatment

For weight management , NICE technology appraisal guidance supports semaglutide 2.4 mg (Wegovy) for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 30 kg/m in exceptional circumstances), as part of a specialist weight management service

Injectables: Which One is Better for Me

Compounding this pressure is the need to maintain strict compliance with evolving regulatory standards